- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00948636
Stem Cell Related Donor Safety Study (RDSafe)
A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life
The study tests the hypothesis that related hematopoietic stem cell donors are at a higher risk for acute medical and psychological toxicity associated with the donation process compared to adult unrelated hematopoietic stem cell donors.
The study will also assess the hypothesis that young (<18 years) and older (>60 years) related donors are at increased risk for toxicity associated with donation compared to younger adult donors by describing the adverse events reported in these populations.
An ancillary study of the psychological impact of donation on health-related quality of life (HRQoL) will enroll related donors and compare them to an age-matched normative cohort.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85006
- Banner Good Samaritan Medical Center
-
-
California
-
San Diego, California, United States, 92093
- University of California, San Diego
-
San Francisco, California, United States, 94143
- University of California, San Francisco
-
-
District of Columbia
-
Washington, D.C., District of Columbia, United States, 20010
- Children's National Medical Center
-
-
Florida
-
Orlando, Florida, United States, 32804
- Florida Center for Cellular Therapy
-
Saint Petersburg, Florida, United States, 33701
- All Children's Hospital
-
Tampa, Florida, United States, 33612
- H. Lee Moffitt Cancer Center
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Children's Healthcare of Atlanta
-
Atlanta, Georgia, United States, 30322
- Winship Cancer Institute
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago
-
Chicago, Illinois, United States, 60014
- Children's Memorial Medical Center
-
-
Indiana
-
Beech Grove, Indiana, United States, 46107
- Indiana Blood and Marrow Transplantation, LLC
-
Indianapolis, Indiana, United States, 46202
- Riley Hospital for Children
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa Hospitals
-
-
Kansas
-
Westwood, Kansas, United States, 66205
- University of Kansas Medical Center
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Kosair Children's Hospital
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
Worcester, Massachusetts, United States, 01655
- Umass Memorial Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Medical Center
-
Detroit, Michigan, United States, 48201
- Barbara Ann Karmanos Cancer Center
-
Grand Rapids, Michigan, United States, 49503
- Helen DeVos Children's Hospital - Spectrum Health
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic, Rochester
-
-
Mississippi
-
Jackson, Mississippi, United States, 39095
- University of Mississippi Medical Center
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospitals and Clinics
-
Saint Louis, Missouri, United States, 63110
- Washington University
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- John Theurer Cancer Center - Hackensack University Medcial Center
-
-
New York
-
Buffalo, New York, United States, 14263
- Roswell Park Cancer Institute
-
Lake Success, New York, United States, 11042
- North Shore University Hospital
-
New Hyde Park, New York, United States, 11040
- Cohen Children's Medical Center of NY
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, United States, 10029
- Mt. Sinai Medical Center
-
Rochester, New York, United States, 14642
- University of Rochester Medical Center
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina at Chapel Hill
-
Durham, North Carolina, United States, 27705
- Duke University Medical Center
-
Winston-Salem, North Carolina, United States, 27157-1082
- Wake Forest University Baptist Medical Center
-
-
Ohio
-
Cincinnati, Ohio, United States, 45236
- Jewish Hospital
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
Cleveland, Ohio, United States, 44106
- University Hospitals of Cleveland/Case Western
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma Health Sciences Center
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health and Science University
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
- Penn State Milton S. Hershey Medical Center
-
Philadelphia, Pennsylvania, United States, 19104
- The Children's Hospital of Philadelphia
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57105
- Avera Cancer Institute
-
-
Texas
-
Dallas, Texas, United States, 75390
- University of Texas Southwestern Medical Center
-
San Antonio, Texas, United States, 78229
- Texas Institute of Medicine and Surgery
-
-
Utah
-
Salt Lake City, Utah, United States, 84113
- University of Utah
-
Salt Lake City, Utah, United States, 84113
- University of Utah, Primary Children's Medical Center
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Washington
-
Seattle, Washington, United States, 98109
- Fred Hutchinson Cancer Research Center
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Medical College Of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Donors of any age providing either a first or second BM or PBSC donation
- Meet donation criteria per institution policies and procedures
- Willing to receive phone follow-up at 1, 6, and 12 months
- Signed informed consent for study participation
For the HRQoL ancillary study, inclusion criteria:
- Related donors age greater than or equal to 5, eligible and consented to the primary trial by the above listed inclusion criteria
- Donors competent to answer psychological assessment questions by themselves, or if a child, should be able to respond to psychological assessment questions and have an appropriate proxy also able to complete the HRQoL proxy interview
- English speaking
- Access to a telephone
- Willing to participate in pre-donation, 1 month and 1 year follow-up interviews
- Signed informed consent for study participation in ancillary study
Exclusion Criteria:
- Per institutional guidelines
- Donors providing unstimulated peripheral blood stem cells or lymphocytes
For the HRQoL ancillary study, exclusion criteria:
- Children less than or equal to 4 years of age
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Related Donors
Related Hematopoietic Stem Cell Donors
|
Collaborators and Investigators
Investigators
- Principal Investigator: Michael A Pulsipher, M.D., Children's Hospital Los Angeles
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 06-DON
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Related Hematopoietic Stem Cell Donors
-
National Cancer Institute (NCI)RecruitingHematopoietic Stem Cell Transplantation | Tissue DonorsUnited States
-
Washington University School of MedicineNational Marrow Donor Program; Predictive BioDiagnostics, LLCCompletedHematopoietic Stem Cell Transplantation | Stem Cell Transplantation, Hematopoietic | Transplantation, Hematopoietic Stem CellUnited States
-
University Hospital, GenevaRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplantation | Autologous Hematopoietic Stem Cell TransplantationSwitzerland
-
Hongnan MoUnknownHematopoietic Stem Cell Transplantation | Thrombocytopoietin | Hematopoietic Stem Cell MobilizationChina
-
Natural Immune Systems IncUnknownStem Cell Mobilization | Hematopoietic Stem Cell Mobilization | Stem Cell HomingUnited States
-
Universitaire Ziekenhuizen KU LeuvenUnknownHematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplantation, Allogeneic
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Duke University; H. Lee Moffitt Cancer Center and...Not yet recruitingHematopoietic Stem Cell TransplantUnited States
-
National Cancer Institute (NCI)RecruitingHematopoietic Stem Cell TransplantationUnited States
-
Seoul National University HospitalNational Institute of Food and Drug Safety Evaluation (Republic of Korea)RecruitingHematopoietic Stem Cell TransplantationKorea, Republic of
-
Children's Hospital Medical Center, CincinnatiRecruitingHematopoietic Stem Cell TransplantUnited States